• 2012

Company Description

Clementia is a biopharmaceutical company dedicated to bringing effective new treatments to people who have none.

Clementia is a biopharmaceutical company dedicated to bringing effective new treatments to people who have none. Clementia is rapidly developing its first lead product candidate, palovarotene, to treat fibrodysplasia ossificans progressiva (FOP), an ultra-rare and severely disabling disorder, and other diseases.